ReviewMedicine and pharmacy reports2025
Multimodal imaging of cervical lymphadenopathy: diagnostic value and clinical applications.
Review in Medicine and pharmacy reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cervical lymphadenopathy encompasses a broad spectrum of malignant conditions, including metastatic involvement from head and neck or distant primaries, as well as primary lymphoid malignancies. Accurate imaging assessment is critical for the differential diagnosis, staging, and treatment planning. Advances in imaging now enable detailed evaluation of nodal morphology, vascularity, stiffness, and metabolic activity. Methods: A narrative review was conducted using PubMed, Web of Science, and Google Scholar to identify studies published between January 2015 and June 2025 on imaging evaluation of cervical lymphadenopathy. The diagnostic performance, strengths, and limitations of various imaging techniques were summarized, with emphasis on recent advances and multimodal strategies. Results: Conventional ultrasonography remains the first-line modality for superficial nodes, with Doppler and elastography improving characterization. Shear wave elastography offers quantitative stiffness assessment, enhancing specificity when combined with grayscale ultrasonography. Computed tomography and magnetic resonance imaging provide cross-sectional evaluation of deep or inaccessible nodal levels, with the latter offering superior soft-tissue contrast and functional techniques such as diffusion-weighted imaging. Fluorodeoxyglucose positron emission tomography contributes with metabolic information, improving detection of occult metastases and aiding systemic staging. No single modality is definitive; combined approaches yield higher accuracy and better surgical planning. Emerging technologies, including image fusion, and radiomics, show promise for refining diagnosis. Conclusion: An integrated, multimodal imaging approach optimizes the evaluation of cervical lymph node metastases. Future developments in functional imaging, quantitative analysis, and artificial intelligence may further enhance diagnostic precision and enable personalized management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.